Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What upper market value could the Point-Of-Care Molecular Diagnostics Market reach by 2030 starting from 2026 levels?
The point-of-care molecular diagnostics market has experienced significant expansion in its size over recent years. Forecasts indicate it will expand from $3.98 billion in 2025 to $4.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.0%. Factors contributing to its historical growth include the rising occurrence of infectious diseases, an increase in emergency diagnostic testing, a greater need for quick clinical decision support, advancements in molecular assay technologies, and the expanded adoption of POC diagnostics within hospital settings.
The point-of-care molecular diagnostics market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $7.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.7%. Factors contributing to this growth during the forecast period include the greater embrace of home-based molecular testing, augmented investments in rapid diagnostics infrastructure, the broadening of respiratory and oncology testing applications, the increasing incorporation of cloud-based diagnostic platforms, and a heightened emphasis on detecting diseases early. Key trends defining the forecast period encompass a surge in the adoption of rapid molecular testing platforms, a heightened demand for decentralized diagnostic solutions, the expanding integration of automated sample processing, a wider array of syndromic testing panels, and an amplified focus on achieving quick turnaround times.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp
Which Drivers Are Influencing Long-Term Growth In The Point-Of-Care Molecular Diagnostics Market?
The escalating prevalence of infectious and respiratory diseases is anticipated to significantly fuel the expansion of the point-of-care molecular diagnostics market. Respiratory infections, stemming from microorganisms like viruses or bacteria, impact the respiratory system, with transmission occurring through coughing, sneezing, or direct touch. Addressing severe respiratory conditions often involves a range of treatments including inhalers, oral medications, intravenous therapies, and point-of-care molecular diagnostic solutions for patient recovery. For example, in June 2024, the UK Health Security Agency, a UK-based government agency, reported that from week 40 of 2022 to week 15 of 2023, 108 NHS trusts in England documented 1,681 critical care admissions for confirmed influenza. This figure stands in stark contrast to the previous season, which recorded 182 admissions across 114 trusts, rising to 316 by week 39 of 2022. Thus, the rapid increase in infectious and respiratory diseases and related deaths is set to drive the point-of-care-molecular diagnostics market.
How Is The Point-Of-Care Molecular Diagnostics Market Divided Into Segments?
The point-of-care molecular diagnostics market covered in this report is segmented –
1) By Product: Assays And Kits, Instruments And Analyzers
2) By Application: Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), Hospital-Acquired Infections (HAIs), Bloodstream and Sepsis-Related Infections
3) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities
Subsegments:
1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables
2) By Instruments And Analyzers: Microfluidic Devices, Point-of-Care Analyzers
Which Trends Are Guiding The Evolution Of The Point-Of-Care Molecular Diagnostics Market?
Leading companies within the point-of-care molecular diagnostics market are concentrating on delivering sophisticated technological solutions to enhance their presence. These firms are deploying next-generation point-of-care molecular diagnostics technologies and associated services, including enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, among others, for implementation on POC devices designed to quicken analysis times and reduce expenses. An example of this is Sensible Diagnostics, a US-based diagnostics company, which introduced a 10-minute point-of-care PCR system in May 2023. Sensible Diagnostics is drawing upon the expertise Curative acquired through its diagnostics operations during the pandemic. The company reported having processed more than two million molecular point-of-care COVID-19 tests, and its PCR platform boasts a 10-minute turnaround time for results.
Which Major Industry Participants Are Leading The Point-Of-Care Molecular Diagnostics Market Growth?
Major companies operating in the point-of-care molecular diagnostics market are Abbott Laboratories, F Hoffmann La Roche Ltd, BioMérieux SA, Hologic Inc, Becton Dickinson and Company, Siemens Healthineers AG, QuidelOrtho Corporation, Bio Rad Laboratories Inc, Qiagen N V, Biocartis Group NV, DiaSorin S p A, SD Biosensor Inc, Cue Health Inc, Visby Medical Inc, Binx Health Inc, Molbio Diagnostics Pvt Ltd, Credo Diagnostics Biomedical Pvt Ltd, Genetron Health, Mammoth Biosciences Inc, Seegene Inc
Access The Complete Report For Deeper Market Insights:
Which Geographic Areas Are Emerging As Strong Markets For The Point-Of-Care Molecular Diagnostics Market?
North America was the largest region in the point-of-care molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Point-Of-Care Molecular Diagnostics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=7046&type=smp
Browse Through More Reports Similar to the Global Point-Of-Care Molecular Diagnostics Market 2026, By The Business Research Company
Molecular Diagnostics Devices And Equipment Global Market Report 2026
Point Of Care Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report
Biomarker Clinical Phase Outsourcing Services Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company